Related Experiment Video
Updated: Jul 20, 2025
Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Bloody Stool: Is It Really Scary in Kids? Four Benign Cases
Betül Öztürk1, Aytaç Göktuğ1, İlknur Bodur1
1Department of Pediatric Emergency Care, Dr. Sami Ulus Maternity and Child Health and Diseases Training and Research Hospital, Ankara, Turkey.
Insights
A rare side effect of cefdinir, a common antibiotic, can cause bloody-appearing stools in children. Recognizing this uncommon cefdinir side effect prevents unnecessary medical interventions.
Area of Science:
- Pediatric Pharmacology
- Gastrointestinal Therapeutics
- Adverse Drug Reactions
Background:
- Cefdinir, a third-generation oral cephalosporin, is widely prescribed for pediatric infections.
- Commonly reported side effects include diarrhea, nausea, and dyspepsia.
- Rarely, cefdinir can induce a red, bloody appearance of stools.
Observation:
- This case report details four pediatric patients presenting to the emergency department with bloody stools.
- The presentation was directly linked to recent cefdinir administration.
- This rare adverse effect can cause significant alarm to caregivers and clinicians.
Findings:
- The red, bloody stool appearance associated with cefdinir is an uncommon but documented phenomenon.
- Prompt recognition of this side effect is crucial for accurate diagnosis.
- Distinguishing drug-induced changes from actual gastrointestinal bleeding is essential.
Implications:
- Awareness of rare cefdinir side effects is vital for healthcare providers.
- Knowledge of this adverse reaction can prevent unnecessary diagnostic procedures and treatments.
- This understanding can lead to more efficient patient management and resource allocation.
Abstract:
Cefdinir is a third-generation oral cephalosporin used frequently in the pediatric population. The most common side effects of cefdinir are diarrhea, nausea and dyspepsia. The side effect of turning the stool color to red and giving a bloody appearance, which is alarming for both families and physicians, is very rare. In this case report, we discussed 4 cases who referred to the emergency department with bloody stool due to the use of cefdinir. The important conclusion to be drawn from this case report is to know the rare side effects of commonly used drugs such as cefdinir. This will save time and resources and prevent unnecessary interventions on the patient.
Related Concept Videos
01:25Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
01:30Serum Laboratory Studies, Stool Test, Breath Test
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.